4/A

FORM 4/A SUBMISSION

Company: Allogene Therapeutics, Inc.
Filed: February 13, 2019
Period of Report: October 15, 2018
Accession Number: 0001209191-19-009724

View Document ↗ View on SEC.gov ↗